Apeloa Pharmaceutical Co.,Ltd. (000739.SZ) has released its third quarter report for 2026.
For the first three quarters, the company achieved operating revenue of 6.835 billion yuan, representing a year-on-year decrease of 11.97%.
Net profit attributable to shareholders of the listed company stood at 614 million yuan, down 12.37% year-on-year.
Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 568 million yuan, a year-on-year decline of 12.22%.
Basic earnings per share came in at 0.5309 yuan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments